Share

October 2022; 12 (5) Commentary

Coordination of Care Among Physical Therapists and Neurologists in Huntington Disease

Nora E. Fritz, Deb Kegelmeyer, Ashwini K. Rao, Lori Quinn, Martha A. Nance, Anne Kloos
First published August 24, 2022, DOI: https://doi.org/10.1212/CPJ.0000000000200073
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
44

Share

Article Information

vol. 12 no. 5 377-381
DOI: 
https://doi.org/10.1212/CPJ.0000000000200073
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
2163-0402
Online ISSN: 
2163-0933
History: 
  • Received October 19, 2021
  • Accepted July 18, 2022
  • First Published August 24, 2022.

Article Versions

Copyright & Usage: 
© 2022 American Academy of Neurology

Author Disclosures

    1. Nora E. Fritz, PhD, PT, DPT, NCS,
    2. Deb Kegelmeyer, MS, PT, DPT, GCS,
    3. Ashwini K. Rao, EdD, OTR/L, FAOTA,
    4. Lori Quinn, EdD, PT,
    5. Martha A. Nance, MD and
    6. Anne Kloos, PhD, PT, NCS
  1. Nora E. Fritz, PhD, PT, DPT, NCS,
    2. Scientific Advisory Boards:

    1. (1) Served on MS Scientific Advisory Board for Helius Medical<br>(2) Serve on the DSMB of an R33 Grant at my University

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. (1) Honoraria provided from the study Sponsors - Huntington <br>Study Group, European Huntington Disease Network, The Griffin <br>Foundation<br>(2) Honoraria for speaking at Consortium of Multiple Sclerosis <br>Centers Annual Meeting

    Editorial Boards:

    1. (1) Journal of Neurologic Physical Therapy

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. (1) Employed at Wayne State University, Associate Professor, <br>2015- present.

    Consultancies:

    1. (1) TEVA

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. (1) TEVA #TV50717-NDG-60338 - PI - 2022-2023

    Research Support, Government Entities:

    1. (1) NIH #HD102337 - CoPI - 2021-2026

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. (1) National Multiple Sclerosis Society # RG2111-38718 - <br>2022-2025<br>(2) National Multiple Sclerosis Society #PP-1912-35300 - <br>2020-2021<br>(3) Consortium of Multiple Sclerosis Centers Pilot Grant - <br>2020-2021

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Deb Kegelmeyer, MS, PT, DPT, GCS,
    3. Scientific Advisory Boards:

    1. None

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. None

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. 1. Medbridge - I receive royalties for online continuing <br>education courses that I created. 2016 to present<br>McGraw-Hill Publishing - I receive royalties for authorship <br>of a book 2016 to present

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. I do consultant work with Create a Better You which is owned <br>by Neuvanta LLC

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. I am on the board of Neuvanta LLC

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. Honda R&D - I have done research related to exoskeleton <br>robotic devices for clients with stroke that is funded <br>through Honda R&D. Money is received in the form of release <br>time paid to Ohio State University.

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. Michael J Fox Foundation - I am an investigator on a study <br>funded by the MJFF.

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. Multiple legal firms since 2005. The primary firm for which <br>I <br>have done expert testimony is Reminger

  3. Ashwini K. Rao, EdD, OTR/L, FAOTA,
    4. Scientific Advisory Boards:

    1. None

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. None

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. Non-profit entity: Huntington's Disease Society of America

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. National Science Foundation, Grant No: 1838725. Role: PI. Years: 4<br>National Institute of Health, Grant No: R56AG061817. Role: Co-PI. Years: 1<br>New York State Department of Health. Grant No: DOH01-C31425GG-3450000. <br>Role: Co-I. Years: 5<br>National Institute of Health, Grant No: U01NS055903. Role: Site PI. Years: 4<br>National Institute of Health, Grant No: U01NS113851. Role: Site PI. Years: 5

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. None

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. Lori Quinn, EdD, PT,
    5. Scientific Advisory Boards:

    1. None

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. (1) Huntington Study Group, stipend

    Editorial Boards:

    1. (1) Physical Therapy Journal, Editorial Board member, 2017-present<br>(2) Journal of Huntington's Disease, Associate Editor,2017-present

    Patents:

    1. NONE

    Publishing Royalties:

    1. (1) Documentation for Rehabilitation: A guide to clinical decision making in physical therapy. Elsevier Publishing Company

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. (1) Huntington Disease Study Group<br>(2) Jacques and Gloria Gossweiller Foundation<br>(3) Parkinson's Foundation

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  5. Martha A. Nance, MD and
    6. Scientific Advisory Boards:

    1. Executive Committee Huntington Study Group<br>Roche HDGENERATION1 DSMB<br>Uniqure DSMB<br>Novartis SAB

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. spouse received travel funding from Novocure<br>I have received travel funding from Huntington Study Group<br>I have received travel funding/honoraria from Parkinson <br>Study Group<br>I have received travel funding from Roche<br>I have received travel funding/speaker honorarium from <br>Parkinson's Foundation<br>I have received travel funding from Huntington Disease <br>Society of America<br>I received travel funding/speaker honorarium from <br>American Academy of Neurology

    Editorial Boards:

    1. Associate Editor, Journal of Huntington's Disease 2012-<br>present<br>Editorial board, Journal of Clinical Movement Disorders, <br>2020-present

    Patents:

    1. NONE

    Publishing Royalties:

    1. chapter in Juvenile Huntington's disease and other <br>trinucleotide repeat disorders, Oxford University Press, <br>2009

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. TEVA<br>Neurocrine

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. Huntington's Disease Society of America<br>Parkinson's Foundation<br>CHDI<br>Park Nicollet Institute

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  6. Anne Kloos, PhD, PT, NCS
    7. Scientific Advisory Boards:

    1. None

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. None

    Editorial Boards:

    1. Associate Editor of Journal of Neurologic Physical Therapy

    Patents:

    1. NONE

    Publishing Royalties:

    1. Medbridge Continuing Education courses<br>Neurologic Rehabilitation, McGraw Hill Education, 2017

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. Michael J. Fox Foundation, Huntington's Disease Society of <br>America

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. Program in Physical Therapy (NEF), Wayne State University, Detroit MI; Physical Therapy Division (DK, AK), School of Health and Rehabilitation Sciences, The Ohio State University, Columbus; Program in Physical Therapy (AKR), Department of Rehabilitative and Regenerative Medicine, G.H. Sergievsky Center, Columbia University, New York; Department of Biobehavioral Sciences (LQ), Teachers College, Columbia University, New York; and Hennepin County Medical Center (MAN), Minneapolis.
  1. Correspondence
    Dr. Fritz nora.fritz{at}wayne.edu

Article usage

Article usage: August 2022 to October 2023

AbstractFullPdfSource
Aug 202238308Highwire
Sep 202212300Highwire
Oct 20225663717Highwire
Nov 202259165Highwire
Dec 202219712Highwire
Jan 202310053Highwire
Feb 20237250Highwire
Mar 20235122Highwire
Apr 20233321Highwire
May 20234243Highwire
Jun 20232300Highwire
Jul 20234311Highwire
Aug 20233112Highwire
Sep 20232600Highwire
Oct 20235010Highwire

The Nerve!: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. [email protected]
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

  • No related articles found.

Alert Me